MBII
Income statement / Annual
Last year (2021), Marrone Bio Innovations, Inc.'s total revenue was $44.31 M,
an increase of 44,210.00% from the previous year.
In 2021, Marrone Bio Innovations, Inc.'s net income was -$16.55 M.
See Marrone Bio Innovations, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
| Period Ended |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
12/31/2012 |
| Operating Revenue |
$44.31 M |
$100.00 K |
$29.37 M |
$21.22 M |
$18.17 M |
$14.04 M |
$9.80 M |
$9.14 M |
$14.54 M |
$7.14 M |
| Cost of Revenue |
$17.06 M
|
$40.00 K
|
$13.26 M
|
$10.91 M
|
$10.53 M
|
$9.52 M
|
$9.26 M
|
$9.44 M
|
$10.74 M
|
$4.33 M
|
| Gross Profit |
$27.25 M
|
$60.00 K
|
$16.11 M
|
$10.31 M
|
$7.64 M
|
$4.52 M
|
$545.00 K
|
-$302.00 K
|
$3.81 M
|
$2.81 M
|
| Gross Profit Ratio |
0.61
|
0.6
|
0.55
|
0.49
|
0.42
|
0.32
|
0.06
|
-0.03
|
0.26
|
0.39
|
| Research and Development Expenses |
$12.08 M
|
$30.00 K
|
$14.03 M
|
$10.66 M
|
$10.82 M
|
$9.67 M
|
$13.50 M
|
$19.28 M
|
$17.81 M
|
$12.74 M
|
| General & Administrative Expenses |
$0.00
|
$75.00 K
|
$30.07 M
|
$19.16 M
|
$19.81 M
|
$18.51 M
|
$26.50 M
|
$28.95 M
|
$15.02 M
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$30.57 M
|
$75.00 K
|
$30.07 M
|
$19.16 M
|
$19.81 M
|
$18.51 M
|
$26.50 M
|
$28.95 M
|
$15.02 M
|
$0.00
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$10.29 M
|
| Operating Expenses |
$42.65 M
|
$105.00 K
|
$44.10 M
|
$29.82 M
|
$30.63 M
|
$28.18 M
|
$40.00 M
|
$48.23 M
|
$32.83 M
|
$23.04 M
|
| Cost And Expenses |
$59.71 M
|
$145.00 K
|
$57.36 M
|
$40.72 M
|
$41.16 M
|
$37.70 M
|
$49.26 M
|
$57.67 M
|
$43.57 M
|
$27.37 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.00 K
|
$37.00 K
|
$51.00 K
|
$59.00 K
|
$49.00 K
|
$16.00 K
|
| Interest Expense |
$1.57 M
|
$4.00 K
|
$1.47 M
|
$2.51 M
|
$7.73 M
|
$7.30 M
|
$4.36 M
|
$2.91 M
|
$6.00 M
|
$2.47 M
|
| Depreciation & Amortization |
$4.57 M
|
$3.56 M
|
$3.15 M
|
$1.89 M
|
$2.04 M
|
$2.24 M
|
$3.51 M
|
$2.58 M
|
$976.00 K
|
$613.00 K
|
| EBITDA |
-$10.37 M |
$3.51 M |
-$32.53 M |
-$15.82 M |
-$21.15 M |
-$21.53 M |
-$35.86 M |
-$46.17 M |
-$21.52 M |
-$35.72 M |
| EBITDA Ratio |
-0.23
|
35.09
|
-1.11
|
-0.75
|
-1.16
|
-1.53
|
-3.66
|
-5.05
|
-1.48
|
-5
|
| Operating Income Ratio |
-0.34
|
-171.95
|
-0.95
|
-0.92
|
-1.27
|
-1.68
|
-4.03
|
-5.31
|
-2
|
-3.34
|
| Total Other Income/Expenses Net |
-$1.57 M
|
$17.14 M
|
-$9.19 M
|
-$709.00 K
|
-$7.93 M
|
-$7.41 M
|
-$4.27 M
|
-$3.13 M
|
$536.00 K
|
-$14.96 M
|
| Income Before Tax |
-$16.51 M
|
-$53.00 K
|
-$37.18 M
|
-$20.21 M
|
-$30.93 M
|
-$31.07 M
|
-$43.73 M
|
-$51.66 M
|
-$28.49 M
|
-$38.79 M
|
| Income Before Tax Ratio |
-0.37
|
-0.53
|
-1.27
|
-0.95
|
-1.7
|
-2.21
|
-4.46
|
-5.65
|
-1.96
|
-5.43
|
| Income Tax Expense |
$45.00 K
|
$0.00
|
$0.00
|
$0.00
|
-$201.00 K
|
-$109.00 K
|
$92.00 K
|
-$219.00 K
|
$0.00
|
$0.00
|
| Net Income |
-$16.55 M
|
-$53.00 K
|
-$37.18 M
|
-$20.21 M
|
-$30.93 M
|
-$31.07 M
|
-$43.73 M
|
-$51.66 M
|
-$28.49 M
|
-$38.79 M
|
| Net Income Ratio |
-0.37
|
-0.53
|
-1.27
|
-0.95
|
-1.7
|
-2.21
|
-4.46
|
-5.65
|
-1.96
|
-5.43
|
| EPS |
-0.0947 |
-0.0004 |
-0.32 |
-0.2 |
-1.06 |
-1.26 |
-1.79 |
-2.32 |
-3.26 |
-2.12 |
| EPS Diluted |
-0.0947 |
-0.0004 |
-0.32 |
-0.2 |
-1.06 |
-1.26 |
-1.79 |
-2.32 |
-3.2 |
-2.12 |
| Weighted Average Shares Out |
$174.83 M
|
$148.89 M
|
$117.98 M
|
$101.25 M
|
$29.24 M
|
$24.62 M
|
$24.47 M
|
$22.31 M
|
$8.73 M
|
$18.27 M
|
| Weighted Average Shares Out Diluted |
$174.83 M
|
$148.89 M
|
$117.98 M
|
$101.25 M
|
$29.24 M
|
$24.62 M
|
$24.47 M
|
$22.31 M
|
$8.91 M
|
$18.27 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
